tiprankstipranks
Eloxx Pharmaceuticals Inc (ELOX)
OTHER OTC:ELOX
US Market
ELOX
Eloxx Pharmaceuticals
RESEARCH TOOLSreports
Want to see ELOX full AI Analyst Report?

Eloxx Pharmaceuticals (ELOX) Income Statement

285 Followers

Eloxx Pharmaceuticals Income Statement

Last quarter (Q3 2023), Eloxx Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Eloxx Pharmaceuticals's net income was $-3.59M. See Eloxx Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 23Mar 22Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 6.44M$ 34.42M$ 66.02M$ 29.44M$ 50.55M
Depreciation and Amortization
$ 245.00K$ 695.00K$ 960.00K$ 571.00K$ 559.00K
EBITDA
$ -6.44M$ -31.75M$ -64.51M$ -32.60M$ -48.70M
Operating Income
$ -6.44M$ -34.42M$ -66.02M$ -33.45M$ -50.55M
Other Income/Expenses
$ 443.00K$ -1.65M$ -709.00K$ -1.12M$ -319.00K
Pretax Income
$ -6.00M$ -36.06M$ -66.73M$ -34.58M$ -50.87M
Net Income
$ -6.00M$ -36.06M$ -66.73M$ -34.58M$ -50.87M
Per Share Metrics
Basic EPS
$ -0.49$ -16.65$ -38.15$ -34.47$ -53.46
Diluted EPS
$ -0.49$ -16.65$ -38.15$ -34.47$ -53.46
Weighted Average Shares Outstanding
 12.35M 2.17M 1.75M 1.00M 951.58K
Weighted Average Shares Outstanding (Diluted)
 12.35M 2.17M 1.75M 1.00M 951.58K
Currency in USD

Eloxx Pharmaceuticals Earnings and Revenue History